Precision BioSciences Q1 EPS $1.70 Beats $(1.91) Estimate, Sales $17.58M Beat $6.02M Estimate
Portfolio Pulse from Benzinga Newsdesk
Precision BioSciences (NASDAQ:DTIL) reported Q1 earnings of $1.70 per share, surpassing the $(1.91) estimate, marking a 124.64% increase from last year. Sales reached $17.58M, beating the $6.02M estimate, a 100.27% increase from the previous year.
May 13, 2024 | 11:03 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Precision BioSciences reported a significant beat on both earnings and sales estimates for Q1, with earnings per share at $1.70 against a $(1.91) estimate and sales of $17.58M against a $6.02M estimate.
The substantial beat on both earnings per share and sales estimates for Precision BioSciences indicates a strong financial performance and operational efficiency, likely leading to positive investor sentiment and a potential short-term increase in stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100